Finny logo
Finny logo

7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $15/month, without ads. Start a trial. Go ad free!

BBH vs XLV

Both BBH and XLV are ETFs. BBH has a lower 5-year return than XLV (9.1% vs 13.49%). BBH has a higher expense ratio than XLV (0.35% vs 0.13%). Below is the comparison between BBH and XLV.

BBH XLV
Segment Equity: Global Biotech Equity: U.S. Health Care
Issuer VanEck State Street Global Advisors
Net Assets $478.8M $25.69B
Expense Ratio 0.35% 0.13%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.36% 1.49%
Underlying Index MVIS US Listed Biotech 25 Index S&P Health Care Select Sector Index
YTD Return 3.49% 3.48%
1-Year Return 25.76% 16.75%
3-Year Return 11.90% 13.48%
5-Year Return 9.10% 13.49%
10-Year Return N/A 15.85%

BBH description

The Fund seeks to replicate the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The Index is comprised of common stocks and depository receipts of US exchange-listed companies in biotechnology sector.

BBH performance & returns

YTD Return 3.49%
1-Month Return 1.50%
3-Month Return 6.05%
1-Year Return 25.76%
3-Year Return 11.90%
5-Year Return 9.10%
10-Year Return N/A
BBH expense ratio is 0.35%.

BBH holdings

Top 10 Holdings (61.45% of Total Assets)

Name Symbol % Assets
Amgen Inc AMGN 14.27%
Gilead Sciences Inc GILD 7.23%
Moderna Inc MRNA 5.48%
Regeneron Pharmaceuticals Inc REGN 5.47%
Exact Sciences Corp EXAS 5.28%
Alexion Pharmaceuticals Inc ALXN 4.92%
IQVIA Holdings Inc IQV 4.91%
Biogen Inc BIIB 4.75%
Vertex Pharmaceuticals Inc VRTX 4.59%
Illumina Inc ILMN 4.55%

Other relevant BBH comparisons

You may also want to check out the following BBH comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

XLV description

The Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index. Under normal market conditions, the fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.

XLV performance & returns

YTD Return 3.48%
1-Month Return 4.60%
3-Month Return 9.77%
1-Year Return 16.75%
3-Year Return 13.48%
5-Year Return 13.49%
10-Year Return 15.85%
XLV expense ratio is 0.13%.

XLV holdings

Top 10 Holdings (51.66% of Total Assets)

Name Symbol % Assets
Johnson & Johnson JNJ 9.45%
UnitedHealth Group Inc UNH 7.59%
Pfizer Inc PFE 5.16%
Merck & Co Inc MRK 4.98%
Thermo Fisher Scientific Inc TMO 4.90%
Abbott Laboratories ABT 4.87%
AbbVie Inc ABBV 3.93%
Danaher Corp DHR 3.79%
Medtronic PLC MDT 3.54%
Bristol-Myers Squibb Company BMY 3.45%

Other relevant XLV comparisons

You may also want to check out the following XLV comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
Follow Us